8-K: Abbott Labs Announces Retirement Plan Blackout Period
Employee Benefit Plan Blackout Notice
Abbott Laboratories has announced a temporary blackout period for its employee retirement plans due to administrative changes, restricting participant transactions.
Summary
- Abbott Laboratories received a notice on November 18, 2025, regarding a blackout period for its U.S. and Puerto Rico Stock Retirement Plans.
- The blackout is required for administrative changes, including changing recordkeepers, trustees for certain U.S. Plan funds, and custodians for certain P.R. Plan funds.
- During the blackout, Plan participants will be unable to engage in transactions involving their Plan accounts, such as changing contribution rates, directing or diversifying investments (including Abbott common shares), making rollover contributions, or obtaining a Plan loan, withdrawal, or distribution.
- The blackout period is expected to begin on December 24, 2025, at 12 p.m. CST and conclude during the week of January 11, 2026.
- Directors and executive officers were notified on November 21, 2025, of specific trading restrictions on Abbott common shares during this period, in compliance with Section 306 of the Sarbanes-Oxley Act of 2002 and Rule 104 of Regulation BTR.
Sentiment
Score: 5
Explanation: The filing announces a temporary blackout period for employee retirement plans due to necessary administrative changes. While it causes temporary inconvenience and restricts participant access to their accounts, it is a standard procedure for such transitions and is not indicative of underlying operational or financial issues.
Negatives
- Plan participants will experience a temporary inability to manage their retirement plan investments, including changing contribution rates, diversifying investments, or accessing funds through loans, withdrawals, or distributions.
- Directors and executive officers are prohibited from directly or indirectly purchasing, selling, or otherwise transferring any equity security of Abbott during the blackout period, regardless of their participation in the Plans.
Risks
- Participants face a temporary inability to manage their retirement plan investments, potentially limiting their flexibility to react to market changes or access their funds during the blackout period.
Future Outlook
The blackout period is a temporary measure for administrative changes, with an expected end during the week of January 11, 2026. After this, participants are expected to regain full access to their plan accounts.
Management Comments
- Plan participants will be unable to engage in transactions involving the assets held in their Plan accounts, including changing contribution rates, directing or diversifying investments (including investments in Abbott common shares), or obtaining a Plan loan, withdrawal, or distribution.
- During the Blackout Period and for two years after the ending date of the Blackout Period, a security holder or other interested person may obtain, without charge, information regarding the Blackout Period, including the actual beginning and ending dates of the Blackout Period, by submitting a request to Abbott Laboratories, 100 Abbott Park Road, Abbott Park, Illinois 60064, Attn: Divisional Vice President, Compensation and Benefits; (224) 667-6100.
- As a director or executive officer of Abbott, you are subject to restrictions under Section 306(a) of the Sarbanes-Oxley Act of 2002 (Sarbanes-Oxley) and Rule 104 of Regulation BTR under the Securities Exchange Act of 1934 (Regulation BTR).
- You are already precluded during this Blackout Period from trading in Abbott securities under Abbott's general insider trading policy, which disallows trades during specific periods (in this case, from December 15, 2025, until after the fourth quarter earnings release). Nevertheless, we are required by Sarbanes-Oxley and Regulation BTR to inform you that, during the Blackout Period, you are generally prohibited from directly or indirectly purchasing, selling, or otherwise transferring any equity security of Abbott.
Industry Context
Temporary blackout periods for employee benefit plans are standard procedures when companies undertake significant administrative changes, such as switching recordkeepers or trustees. These are often required to ensure compliance and smooth transitions, minimizing long-term disruption.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Policy Implementation/Compliance | Implementation of a temporary trading restriction on directors and executive officers during the blackout period, in compliance with Section 306 of the Sarbanes-Oxley Act of 2002 and Rule 104 of Regulation BTR. | 2025-12-24 | Ensures regulatory compliance and prevents potential conflicts of interest or unfair advantage during a period when plan participants cannot trade. |
Stakeholder Impact
- **Employees (Plan Participants)**: Will experience a temporary inability to manage their retirement plan investments, including changing contribution rates, diversifying investments, or making withdrawals/loans.
- **Directors and Executive Officers**: Will be subject to specific trading restrictions on Abbott common shares during the blackout period, in addition to existing insider trading policies.
- **Shareholders**: Minimal direct impact, as the event is administrative and temporary, not related to company performance or strategy.
Next Steps
- The blackout period is expected to begin on December 24, 2025, and end during the week of January 11, 2026.
- Participants will regain full access to their plan accounts after the blackout period concludes.
- Information regarding the blackout period, including actual start and end dates, can be obtained by contacting Abbott Laboratories for two years after the ending date.
Key Dates
| Date | Description |
|---|---|
| 2025-11-18 | Date of earliest event reported; Abbott Laboratories received notice of the blackout period from plan administrators. |
| 2025-11-21 | Abbott Laboratories sent notice to its directors and executive officers informing them of the blackout period and trading restrictions. |
| 2025-12-15 | Start date of Abbott's general insider trading policy prohibition on trading for directors and executive officers (until after Q4 earnings release). |
| 2025-12-24 | Expected start date of the Blackout Period at 12 p.m. CST. |
| 2026-01-11 | Expected end date of the Blackout Period (during the week of January 11, 2026). |
Keywords
Abbott Laboratories, ABT, SEC Filing, 8-K, Blackout Period, Employee Benefits, Retirement Plan, Stock Retirement Plan, Sarbanes-Oxley, Regulation BTR, Trading Restrictions, Recordkeeper Change, Trustee Change, Custodian Change
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.